Related incretin medicines have their own safety profiles, and the Mounjaro Side Effects article gives a broader example of how tolerability questions are usually discussed for approved therapy
Additionally, spreading meals evenly throughout the day and avoiding late-night eating supports natural GLP1 rhythms
Compare these modest outcomes to the first month results on semaglutide , where users commonly report 4-8 pounds of weight loss alongside significant appetite suppression
By 2024, an estimated 12% of American adults reported taking a GLP-1 medication for diabetes, weight loss, or heart disease, according to data from the Kaiser Family Foundation
Zepbound ( Tirzepatide ): Zepbound is a newer medication that works through two pathways to help with both weight loss and blood sugar control
Gallbladder disease: Incretin-based therapies have been associated with an increased risk of cholelithiasis (gallstones) and cholecystitis (gallbladder inflammation), as noted in the UK SmPCs for licensed comparators such as semaglutide and tirzepatide
